Skip to content

Advm stock price target

Advm stock price target

Adverum Biotechnologies, Inc. (ADVM): What’s Inside the ... Mar 09, 2020 · On Friday, shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) marked $11.87 per share versus a previous $13.30 closing price. With having a -10.75% loss, an insight into the fundamental values of Adverum Biotechnologies, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. (ADVM) - Adverum Biotech Shares Move Higher On Positive ... Feb 11, 2020 · Roughly doubling the economic contribution of ADVM-022 in Chardan's model, Amusa doubled the price target on the shares to $20 and upgraded the stock from Neutral to Buy. Is It Right Time to Be Bearish on Adverum Biotechnologies ... Mar 09, 2020 · The stock was given Neutral rating by Chardan Capital Markets in its report released on September 13, 2019, the day when the price target on the stock was placed at 6. Raymond James was of a view that ADVM is Mkt Perform in its latest report on June 14, 2019. SunTrust thinks that ADVM is worth Hold rating. ADVM Stock | AVALANCHE BIOTECHNOLOGIES Stock Price …

ADVM | Adverum Biotechnologies Inc. Analyst Estimates ...

Find the latest Adverum Biotechnologies, Inc. (ADVM) stock quote, history, news and other vital information to help you with your stock trading and investing. ADVM Stock Price, Forecast & News (Adverum Biotechnologies) Adverum Biotechnologies has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings. Price Target Upside/Downside. According to analysts' consensus price target of $18.50, Adverum Biotechnologies has a potential upside of 106.7% from its current price of Adverum Biotechnologies, Inc. (ADVM) Stock Analysis & News ...

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. The Company is evaluating its gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related

Nov 06, 2019 · 8 Wall Street analysts have issued ratings and price targets for Adverum Biotechnologies in the last 12 months. Their average twelve-month price target is $18.50, suggesting that the stock has a possible upside of 116.88%. The high price target for ADVM is $21.00 and the low price target for ADVM is … Adverum Biotechnologies, Inc. (ADVM) Stock Price, Quote ... Find the latest Adverum Biotechnologies, Inc. (ADVM) stock quote, history, news and other vital information to help you with your stock trading and investing. ADVM Stock Price, Forecast & News (Adverum Biotechnologies)

Find the latest Adverum Biotechnologies, Inc. (ADVM) stock quote, history, news and other vital information to help you with your stock trading and investing.

View Adverum Biotechnologies, Inc. ADVM investment & stock information. Get the latest Adverum Biotechnologies, Inc. ADVM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Cantor upgrades Adverum on positive ADVM-022 data (NASDAQ ...

Adverum Biotechnologies Inc (NASDAQ:ADVM) price target set ...

Average Recommendation: Overweight, Average Target Price: 11.50. Number of Ratings: 6, Current Quarters Estimate: -0.29. FY Report Date: 12 / 2019, Current  Analysts Are Cutting Their Estimates: Here's What You Need To Know. Investors in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) had a good week, as its  Adverum Biotechnologies Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ADVM updated stock price target summary. Stock quote and company snapshot for ADVERUM BIOTECHNOLOGIES INC ( ADVM), including profile, stock chart, recent news and events, analyst opinions,  26 Mar 2020 Additionally, ADVM shares got another “Overweight” rating from Cantor Fitzgerald, setting a target price of $21 on the company's shares,  Based on 7 analysts offering recommendations. Real time Adverum Biotechnologies, Inc. (ADVM) stock price quote, stock graph, news & analysis.

Apex Business WordPress Theme | Designed by Crafthemes